liraglutide Pen Injector [Victoza]
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The Danish drug company Novo Nordisk has paid $58.7m (£45m; €49m) to settle a cluster of seven US lawsuits accusing the company…
Metabolic syndrome is a condition that individuals develop cardiovascular health, diabetes and others complicationsThe dramatic…
Goal: to develop the model of of type 2 diabetes mellitus outcomes validated in Russian clinical conditions and to perform…
Le liraglutide (Victoza ® ) est un peptide produit par la technique de l'ADN recombinant qui presente 97 % d'homologie avec le…
Le liraglutide (Victoza®) est un nouvel analogue du GLP-1. Dans cet article, nous revoyons le concept « incretine » et discutons…